دورية أكاديمية
Distinguishing features of long COVID identified through immune profiling.
| العنوان: | Distinguishing features of long COVID identified through immune profiling. |
|---|---|
| المؤلفون: | Klein J; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA., Wood J; Abilities Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Jaycox JR; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA., Dhodapkar RM; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.; Department of Ophthalmology, USC Keck School of Medicine, Los Angeles, CA, USA., Lu P; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA., Gehlhausen JR; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.; Department of Dermatology, Yale School of Medicine, New Haven, CT, USA., Tabachnikova A; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA., Greene K; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA., Tabacof L; Abilities Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Malik AA; Yale Institute for Global Health, Yale School of Public Health, New Haven, CT, USA., Silva Monteiro V; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA., Silva J; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA., Kamath K; SerImmune, Goleta, CA, USA., Zhang M; SerImmune, Goleta, CA, USA., Dhal A; SerImmune, Goleta, CA, USA., Ott IM; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA., Valle G; Department of Internal Medicine (Pulmonary, Critical Care and Sleep Medicine), Yale School of Medicine, New Haven, CT, USA., Peña-Hernández M; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.; Department of Microbiology, Yale School of Medicine, New Haven, CT, USA., Mao T; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA., Bhattacharjee B; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA., Takahashi T; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA., Lucas C; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.; Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, USA., Song E; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA., McCarthy D; Abilities Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Breyman E; Abilities Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Tosto-Mancuso J; Abilities Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Dai Y; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA., Perotti E; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA., Akduman K; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA., Tzeng TJ; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA., Xu L; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA., Geraghty AC; Department of Neurology and Neurological Sciences, Stanford University, Palo Alto, CA, USA., Monje M; Department of Neurology and Neurological Sciences, Stanford University, Palo Alto, CA, USA.; Howard Hughes Medical Institute, Chevy Chase, MD, USA., Yildirim I; Yale Institute for Global Health, Yale School of Public Health, New Haven, CT, USA.; Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, USA.; Department of Pediatrics (Infectious Diseases), Yale New Haven Hospital, New Haven, CT, USA.; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA., Shon J; SerImmune, Goleta, CA, USA., Medzhitov R; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.; Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, USA.; Howard Hughes Medical Institute, Chevy Chase, MD, USA., Lutchmansingh D; Department of Internal Medicine (Pulmonary, Critical Care and Sleep Medicine), Yale School of Medicine, New Haven, CT, USA., Possick JD; Department of Internal Medicine (Pulmonary, Critical Care and Sleep Medicine), Yale School of Medicine, New Haven, CT, USA., Kaminski N; Department of Internal Medicine (Pulmonary, Critical Care and Sleep Medicine), Yale School of Medicine, New Haven, CT, USA., Omer SB; Yale Institute for Global Health, Yale School of Public Health, New Haven, CT, USA.; Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, USA.; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.; Department of Internal Medicine (Infectious Diseases), Yale School of Medicine, New Haven, CT, USA., Krumholz HM; Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, USA.; Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, CT, USA.; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.; Department of Health Policy and Management, Yale School of Public Health, New Haven, CT, USA., Guan L; Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, USA.; Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA., Dela Cruz CS; Department of Internal Medicine (Pulmonary, Critical Care and Sleep Medicine), Yale School of Medicine, New Haven, CT, USA.; Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, USA., van Dijk D; Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, USA. david.vandijk@yale.edu.; Department of Computer Science, Yale University, New Haven, CT, USA. david.vandijk@yale.edu.; Department of Internal Medicine (Cardiology), Yale School of Medicine, New Haven, CT, USA. david.vandijk@yale.edu., Ring AM; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA. aaron.ring@yale.edu.; Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, USA. aaron.ring@yale.edu., Putrino D; Abilities Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA. david.putrino@mountsinai.org.; Department of Rehabilitation and Human Performance, Icahn School of Medicine at Mount Sinai, New York, NY, USA. david.putrino@mountsinai.org., Iwasaki A; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA. akiko.iwasaki@yale.edu.; Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, USA. akiko.iwasaki@yale.edu.; Howard Hughes Medical Institute, Chevy Chase, MD, USA. akiko.iwasaki@yale.edu. |
| المصدر: | Nature [Nature] 2023 Nov; Vol. 623 (7985), pp. 139-148. Date of Electronic Publication: 2023 Sep 25. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Basingstoke : Nature Publishing Group Original Publication: London, Macmillan Journals ltd. |
| مواضيع طبية MeSH: | Antibodies, Viral*/blood , Antibodies, Viral*/immunology , Herpesvirus 4, Human*/immunology , Hydrocortisone*/blood , Lymphocytes*/immunology , Myeloid Cells*/immunology , Post-Acute COVID-19 Syndrome*/diagnosis , Post-Acute COVID-19 Syndrome*/immunology , Post-Acute COVID-19 Syndrome*/physiopathology , Post-Acute COVID-19 Syndrome*/virology , SARS-CoV-2*/immunology, Humans ; Biomarkers/blood ; Cross-Sectional Studies ; Immunophenotyping ; Machine Learning |
| مستخلص: | Post-acute infection syndromes may develop after acute viral disease 1 . Infection with SARS-CoV-2 can result in the development of a post-acute infection syndrome known as long COVID. Individuals with long COVID frequently report unremitting fatigue, post-exertional malaise, and a variety of cognitive and autonomic dysfunctions 2-4 . However, the biological processes that are associated with the development and persistence of these symptoms are unclear. Here 275 individuals with or without long COVID were enrolled in a cross-sectional study that included multidimensional immune phenotyping and unbiased machine learning methods to identify biological features associated with long COVID. Marked differences were noted in circulating myeloid and lymphocyte populations relative to the matched controls, as well as evidence of exaggerated humoral responses directed against SARS-CoV-2 among participants with long COVID. Furthermore, higher antibody responses directed against non-SARS-CoV-2 viral pathogens were observed among individuals with long COVID, particularly Epstein-Barr virus. Levels of soluble immune mediators and hormones varied among groups, with cortisol levels being lower among participants with long COVID. Integration of immune phenotyping data into unbiased machine learning models identified the key features that are most strongly associated with long COVID status. Collectively, these findings may help to guide future studies into the pathobiology of long COVID and help with developing relevant biomarkers. (© 2023. The Author(s).) |
| التعليقات: | Update of: medRxiv. 2022 Aug 10:2022.08.09.22278592. doi: 10.1101/2022.08.09.22278592. (PMID: 35982667) |
| References: | Ann Transl Med. 2016 Jun;4(11):218. (PMID: 27386492) Nat Med. 2022 Nov;28(11):2406-2415. (PMID: 36138154) Nature. 2021 Jun;594(7862):259-264. (PMID: 33887749) Nat Commun. 2023 Jul 14;14(1):4201. (PMID: 37452024) Nat Med. 2022 Mar;28(3):583-590. (PMID: 35132265) Front Immunol. 2021 Nov 15;12:656797. (PMID: 34867935) Biostatistics. 2007 Jan;8(1):2-8. (PMID: 16702229) J Biomed Inform. 2009 Apr;42(2):377-81. (PMID: 18929686) Arch Intern Med. 2006 May 22;166(10):1092-7. (PMID: 16717171) Lancet Infect Dis. 2015 Aug;15(8):951-9. (PMID: 26163373) Nature. 2021 Jul;595(7866):283-288. (PMID: 34010947) BMJ. 2021 May 19;373:n1098. (PMID: 34011492) Gut. 2022 Jan;71(1):226-229. (PMID: 34083386) Nature. 2022 Dec;612(7941):758-763. (PMID: 36517603) Annu Rev Immunol. 2013;31:563-604. (PMID: 23516985) Arch Clin Neuropsychol. 2021 Jan 15;36(1):126-134. (PMID: 32851403) Nature. 2021 Dec;600(7889):523-529. (PMID: 34634791) Nat Med. 2021 Jul;27(7):1178-1186. (PMID: 33953384) Arch Neurol. 1989 Oct;46(10):1121-3. (PMID: 2803071) Trans R Soc Trop Med Hyg. 2018 Jul 1;112(7):301-316. (PMID: 30007303) J Transl Autoimmun. 2021;4:100100. (PMID: 33880442) Nat Rev Immunol. 2023 Oct;23(10):618-634. (PMID: 37433988) Muscle Nerve. 2005 Jan;31(1):6-19. (PMID: 15599928) Annu Rev Immunol. 2019 Apr 26;37:439-456. (PMID: 31026415) JAMA. 2023 Jun 13;329(22):1934-1946. (PMID: 37278994) Sci Rep. 2016 Aug 02;6:30312. (PMID: 27481573) Lancet. 2022 Aug 6;400(10350):452-461. (PMID: 35934007) Qual Life Res. 2011 Dec;20(10):1727-36. (PMID: 21479777) Lancet. 2021 Feb 13;397(10274):613-629. (PMID: 33484633) Cell Mol Immunol. 2020 Oct;17(10):1095-1097. (PMID: 32895485) Int J Mol Sci. 2022 Jun 29;23(13):. (PMID: 35806214) Clin Endocrinol (Oxf). 2005 Aug;63(2):197-202. (PMID: 16060914) Bioinformatics. 2016 Sep 15;32(18):2847-9. (PMID: 27207943) Science. 2020 Sep 4;369(6508):. (PMID: 32669297) Clin Infect Dis. 2023 Feb 8;76(3):e487-e490. (PMID: 36052466) J Infect Dis. 2005 Mar 15;191(6):985-9. (PMID: 15717276) BMJ Glob Health. 2021 Sep;6(9):. (PMID: 34580069) Pathogens. 2021 Jun 17;10(6):. (PMID: 34204243) Nat Biotechnol. 2018 Dec 03;:. (PMID: 30531897) Lancet Infect Dis. 2020 May;20(5):533-534. (PMID: 32087114) J Clin Sleep Med. 2018 Nov 15;14(11):1849-1857. (PMID: 30373688) BMC Bioinformatics. 2011 Mar 17;12:77. (PMID: 21414208) Front Immunol. 2021 Apr 27;12:625311. (PMID: 33986742) Bioinformatics. 2010 Jan 1;26(1):139-40. (PMID: 19910308) J Infect Dis. 2022 Nov 1;226(9):1593-1607. (PMID: 35429399) Cell Rep Methods. 2022 Feb 28;2(2):. (PMID: 35360706) Occup Med (Lond). 2008 May;58(3):226-7. (PMID: 18441368) Nat Med. 2022 May;28(5):911-923. (PMID: 35585196) JAMA Health Forum. 2023 Mar 3;4(3):e230010. (PMID: 36867420) Cell. 2022 Mar 3;185(5):881-895.e20. (PMID: 35216672) Nat Commun. 2020 Jul 24;11(1):3730. (PMID: 32709840) J Clin Microbiol. 2000 Feb;38(2):712-5. (PMID: 10655372) Diagnostics (Basel). 2018 Sep 11;8(3):. (PMID: 30208578) Cell. 2020 Dec 10;183(6):1479-1495.e20. (PMID: 33171100) Sci Rep. 2020 Mar 24;10(1):5294. (PMID: 32210339) Am J Phys Med Rehabil. 2022 Jan 1;101(1):48-52. (PMID: 34686631) Neurol Neuroimmunol Neuroinflamm. 2023 May 5;10(4):. (PMID: 37147136) J Biomed Inform. 2019 Jul;95:103208. (PMID: 31078660) Nature. 2020 Aug;584(7821):463-469. (PMID: 32717743) J Clin Invest. 2023 Feb 1;133(3):. (PMID: 36454631) Nat Med. 2020 Jul;26(7):1017-1032. (PMID: 32651579) J Exp Med. 2017 Mar 6;214(3):651-667. (PMID: 28130404) Bioinformatics. 2003 Jan 22;19(2):185-93. (PMID: 12538238) J R Soc Med. 2023 Mar;116(3):97-112. (PMID: 36787802) Nat Rev Microbiol. 2023 Mar;21(3):133-146. (PMID: 36639608) Nat Commun. 2020 Jun 1;11(1):2806. (PMID: 32483236) Nat Med. 2021 Apr;27(4):601-615. (PMID: 33753937) BMJ. 2006 Sep 16;333(7568):575. (PMID: 16950834) Med Care. 2003 Nov;41(11):1284-92. (PMID: 14583691) Biometrics. 1988 Sep;44(3):837-45. (PMID: 3203132) |
| معلومات مُعتمدة: | R01 AI157488 United States AI NIAID NIH HHS; R35 GM143072 United States GM NIGMS NIH HHS; U01 FD005938 United States FD FDA HHS; UL1 TR001863 United States TR NCATS NIH HHS |
| المشرفين على المادة: | 0 (Antibodies, Viral) 0 (Biomarkers) WI4X0X7BPJ (Hydrocortisone) |
| تواريخ الأحداث: | Date Created: 20230925 Date Completed: 20231103 Latest Revision: 20240725 |
| رمز التحديث: | 20240726 |
| مُعرف محوري في PubMed: | PMC10620090 |
| DOI: | 10.1038/s41586-023-06651-y |
| PMID: | 37748514 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 1476-4687 |
|---|---|
| DOI: | 10.1038/s41586-023-06651-y |